SCHEMBL22482665

SCHEMBL22482665

CC(C)CCCNCCCN(C)C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.56
PAOX Q6QHF9 1/20 0.46
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
KDM4E B2RXH2 5/20 0.40
ALDH1A1 P00352 2/20 0.39
MEN1 O00255 1/20 0.39
HTT P42858 1/20 0.39
KMT2A Q03164 1/20 0.39
TSHR P16473 1/20 0.38
DPP7 Q9UHL4 2/20 0.37
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
TERT O14746 1/20 0.33
PRMT3 O60678 1/20 0.33
CARM1 Q86X55 1/20 0.33
PRMT6 Q96LA8 1/20 0.33
PRMT1 Q99873 1/20 0.33
PRMT8 Q9NR22 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19516596 0.91 TDP1 (0.52) TDP1PAOXCYP2C9CYP2C19KDM4E
SCHEMBL27435358 0.91 PAOX (0.47) TDP1PAOXCYP2C9CYP2C19KDM4E
SCHEMBL11932523 0.91 CYP2C9 (0.54) TDP1PAOXCYP2C9CYP2C19KDM4E
Hydrochloric Acid SCHEMBL31278439 0.90 PAOX (0.50) TDP1PAOXCYP2C9CYP2C19KDM4E
SCHEMBL23934067 0.86 TDP1 (0.42) TDP1PAOXCYP2C9CYP2C19KDM4E
SCHEMBL30463701 0.83 CYP2C19 (0.50) TDP1PAOXCYP2C9CYP2C19KDM4E
SCHEMBL30463700 0.83 CYP2C19 (0.50) TDP1PAOXCYP2C9CYP2C19KDM4E
SCHEMBL30463704 0.83 CYP2C19 (0.50) TDP1PAOXCYP2C9CYP2C19KDM4E
SCHEMBL15859 0.83 TDP1 (0.75) TDP1PAOXCYP2C9CYP2C19KDM4E
SCHEMBL277921 0.83 LMNA (0.45) CYP2C9CYP2C19ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024098053-A1 POLYMER-NUCLEIC ACID NANOPARTICLES FOR GENE EDITING THE JOHNS HOPKINS UNIVERSITY (US) 2024-05-10 WO disclosed
WO-2023077150-A1 POLYMERS AND NANOPARTICLES FOR INTRAMUSCULAR NUCLEIC ACID DELIVERY THE JOHNS HOPKINS UNIVERSITY (US) 2023-05-04 WO disclosed
US-20220154219-A1 GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS THE JOHNS HOPKINS UNIVERSITY 2022-05-19 US disclosed
WO-2020198145-A1 GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS THE JOHNS HOPKINS UNIVERSITY (US) 2020-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220154219-A1 GENE DELIVERY PARTICLES TO INDUCE TUMOR-DERIVED ANTIGEN PRESENTING CELLS PBK, MICA, STAT3 TDP1 4009/4885PAOX 4460/4885CYP2C9 4839/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.